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Reports of heterogeneity within embryonic stem cell lines suggest that pluripotent stem cells captured in
culture may be less homogeneous than previously assumed. In a recent issue ofCell, Scho¨ler and colleagues
(Han et al., 2010) demonstrate the existence of a dynamic subpopulation of epiblast stem cells that shows
features of earlier pluripotent cells.The immortal growth and cellular versa-
tility of embryonic stem cell (ESC) lines
has made them a popular choice for
studying tissue formation in vitro. Classic
murine ESC lines are derived by adapta-
tion to culture of pluripotent cells from
the inner cell mass of 3-day-old blasto-
cysts. When these ESCs are returned to
the mouse blastocyst, they contribute
to all tissues of the developing embryo
and form chimeric mice, demonstrating
their pluripotency. When a similar deriva-
tion strategy was successfully applied
to human blastocysts, many scientists
presumed the resulting human ESCs
were cellular homologs of murine ESCs,
despite significant differences in colony
morphology (human are flat; murine are
rounded) and growth factor characteris-
tics (human require fibroblast growth
factor [FGF]; murine require leukemia
inhibitory factor [LIF]).
Nearly 10 years passed before a cell
type resembling human ESCs was iso-
lated from mice, by culturing epiblast
layers of slightly later stage murine
embryos (day 5.5 [Brons et al., 2007;
Tesar et al., 2007]). These so-called
murine EpiSCs differ from murine ESCs
in their manifestations of pluripotency.
Although both EpiSCs and ESCs differen-
tiate into tissues of all three embryonic
germ layers and form teratomas when
injected into immune-deficient mice,
EpiSCs contribute to chimeras only rarely
(0.5%) (Brons et al., 2007), whereas
ESCs are defined by their capacity to chi-
merize the embryo and to contribute to
the germ line.
Aside from the clear differences
between human and mouse or betweenESCs and EpiSCs, the nature of
embryo-derived pluripotent cell lines is
proving even more complex. Evidence
suggests that clonal lines of ESCs
are not homogeneous, but instead are
comprised of dynamic subpopulations
resembling subtly different stages in early
development (Hayashi et al., 2008;
Toyooka et al., 2008). In a recent issue
of Cell, Scho¨ler and colleagues likewise
find heterogeneity within single EpiSC
lines, with subpopulations that corre-
spond to distinct stages in epiblast devel-
opment (Han et al., 2010). The authors
suggest that the rare cells that resemble
the earliest epiblast stage may in fact be
responsible for the pluripotent behavior
attributed to EpiSC lines. By showing
that properties previously thought char-
acteristic of an entire cell line may instead
reside in only a fraction of the total
population, the current report under-
scores the importance of understanding
the dynamic, metastable states of the
pluripotent epigenome.
Scho¨ler and colleagues investigated an
EpiSC line derived from a transgenic
mouse that expresses GFP under the
control of an Oct4 promoter construct.
They report the curious observation that
only 0.5% of cells express GFP, whereas
the rest silence the GFP transgene but
maintain Oct4 expression from similar,
endogenous promoter sequences. By
interrogating individual cells and their
clonal offspring, the authors find these
rare EpiSC-Oct4-GFP-positive cells to
be in dynamic equilibrium with the rest
of the EpiSC-Oct4-GFP-negative cells.
Although the mechanism of this preferen-
tial silencing of the GFP construct is neverCell Stem Cell 7,
STEM 824_823determined, it nonetheless provides a
useful tool for separating two subpopula-
tions of EpiSCs. These continually inter-
changing subpopulations are studied in
the rest of the paper and found to be bio-
logically distinct.
The rare Oct4-GFP-positive EpiSCs
perform differently from the GFP-negative
population in two functional assays. First,
upon treatment with MAP kinase inhibi-
tors and LIF, the GFP-positive cells transi-
tion to an ESC-like state with 15-fold
higher efficiency than the GFP-negative
cells. Unlike previous reports, the authors
do not specify the need for enhanced
KLF4 to complete this transition (Guo
et al., 2009; Hanna et al., 2010). Second,
upon injection into blastocysts, the GFP-
positive cells integrate into the ICM with
modest but significant efficiency and
contribute to colonization of the genital
ridge germ cells and coat color in the
resulting chimeras. Cells from the GFP-
negative subpopulation, on the other
hand, showed no ICM integration, contri-
bution to germ cells, or coat color chime-
rism. These results suggest that the scant
GFP-positive subpopulation of EpiSCs
may account for some or all of the occa-
sional ESC-like cell transitions and chime-
rism described in earlier reports (Brons
et al., 2007).
Upon microarray analysis, overall gene
expression patterns were similar between
GFP-positive and GFP-negative EpiSCs.
However, a few key genes differed
between the two subpopulations. Com-
pared to the GFP-negative cells, GFP-
positive cells upregulated some ESC
marker genes (such as Rex1, KLF4,
dppa5), while downregulating EpiSCDecember 3, 2010 ª2010 Elsevier Inc. 641
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Figure 1. Pluripotent Cell Lines Derived from Murine Blastocysts
ESC and EpiSC are composed of metastable, dynamic subpopulations that
may correspond to different stages of in vivo embryonic development.
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SomeDNAmethylation differ-
ences were also noted
between the two cell types,
as well as differences in Oct4
enhancer utilization.
Adding further credibility to
the assertion that metastable
subpopulations of EpiSCs
represent in vivo epiblasts
of different ages, tissues ex-
tracted from early epiblast-
stage embryos (E5.5) shared
gene expression patterns
and Oct4 enhancer utilization
with the GFP-positive subpo-
pulation of EpiSCs, whereas
tissues from embryos at a
later developmental stage
(E7.5) were more similar to
the GFP-negative EpiSCs.
Primitive ectoderm from E5has previously been shown to contribute
to chimera formation, whereas that from
E6 and later cannot. Taking these findings
together, the authors conclude that meta-
stable Oct4-GFP status reflects distinct
EpiSC subpopulations that approximate
different embryonic stages.
Depending on the developmental stage
of cell collection and the derivation condi-
tions, early mouse embryos can generate
stem cell lines with distinct characteris-
tics. These types of lines represent not
only different flavors of pluripotency
(Buecker and Geijsen, 2010; Chou et al.,
2008) but also containmultiplemetastable
epigenetic states, some of which can642 Cell Stem Cell 7, December 3, 2010 ª20interconvert (Figure 1). Perhapswe should
not be surprised that the nature of
embryo-derived stem cells is more
complex than we originally believed.
These findings have significant implica-
tions for research on stem cell lines.
Stem cell biologists will need to determine
whether specific characteristics of
interest are evenly distributed over all cells
or are resident exclusively in a specific
subpopulation. Developmental biologists,
on the other hand, will remain skeptical
about drawing meaningful developmental
conclusions from cell culture studies until
there is precise mechanistic under-
standing of the distinct and metastable10 Elsevier Inc.
STEM 824_823states of pluripotency and
unequivocal correlation of
in vitro cell proxies with their
in vivo equivalents.
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